Peripheral arterial disease

(ulceration and/or gangrene) â€¢ examining the femoral, popliteal and foot pulses. [Adapted from NICE's guideline on peripheral arterial disease, recommendation 1.3.2] ABPI measurement Recommendation 1.3.3 in NICE's guideline on peripheral arterial disease provides guidance on how this should be done. Quality statement 2: Comorbidity assessment Quality statement People with peripheral arterial disease (PAD) are offered an assessment for cardiovascular comorbidities and modifiable risk factors. Rationale People with both asymptomatic and symptomatic PAD have an increased risk of mortality from cardiovascular disease, mainly due to heart attack and stroke. It is therefore important to assess people with PAD for other cardiovascular comorbidities and modifiable risk factors, so that appropriate evidence-based treatment, advice and support can be given to reduce this risk. Quality measures Structure Evidence of local arrangements to ensure that people with PAD are offered an assessment of cardiovascular comorbidities and modifiable risk factors. Data source: Local data collection. Process Proportion of people with PAD who receive an assessment of cardiovascular comorbidities and modifiable risk factors. Numerator: the number of people in the denominator receiving an assessment of cardiovascular comorbidities and modifiable risk factors. Denominator: the number of people with PAD. Data source: Local data collection. Data on the percentage
